Abstract
Aim: In this study, parameters of metabolic syndrome and dehydroepiandrosterone sulfate (DHEAS) levels in obese children and adolescents were evaluated and the associations between these factors were analyzed.
Method: One hundred obese and 40 healthy children/adolescents were included in the study. Pubertal stages, anthropometric and blood pressure measurements were recorded. Levels of fasting serum lipids, glucose, insulin, and DHEAS, and liver function tests were determined. Carotid intima-media thickness (CIMT) was measured using two-dimensional echocardiography. Steatorrhoeic hepatosis was evaluated using abdominal ultrasonography in the obese group.
Results: Mean body weight, body mass index, waist, hip circumference, waist/hip ratio, homeostatic model assessment of insulin resistance, triglycerides, high-density lipoprotein cholesterol, alanine transferase, DHEAS, and CIMT values were significantly higher in the obese group than in the controls. DHEAS levels were found to be positively correlated with waist circumference, waist/hip ratio, and CIMT.
Conclusion: Early determination of metabolic and cardiac dysfunction in obese children is important for the prevention of future complications. Since in this study we found a strong association between DHEAS levels and obesity-related metabolic and cardiovascular risk factors, we believe that this may lead to increased interest in further studies of DHEAS in the search for new treatment approaches.
References
1. ILSI European Overweight and Obesity in Children Task Force. Overweight and obesity in European children and adolescents: causes and consequences, prevention and treatment. The International Live Science Institute. Eur Rep Ser 2000:4–22.Search in Google Scholar
2. Dietz WH. Childhood obesity. In: McMillian JA, DeAngelis CD, Feigin RA, Warshaw JB, editors. Oski’s Pediatrics. Houston: Lippincott Williams and Wilkins, 1999:1784–7.Search in Google Scholar
3. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEA-S: a review. J Clin Pharmacol 1999;39:327–48.10.1177/00912709922007903Search in Google Scholar
4. Nestler JE, Barlascini CO, Clore JN, Blackard WG. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988;66:57–61.10.1210/jcem-66-1-57Search in Google Scholar
5. Barrett-Connor E, Ferrara A. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J Clin Endocrinol Metab 1996;81:59–64.Search in Google Scholar
6. Herrington DM. Dehydroepiandrosterone and coronary atherosclerosis. Ann NY Acad Sci 1995;774:271–80.10.1111/j.1749-6632.1995.tb17387.x-i1Search in Google Scholar
7. Trivedi DP, Khaw KT. Dehydroepiandrosterone sulfate and mortality in elderly men and women. J Clin Endocrinol Metab 2001;86:4171–7.10.1210/jcem.86.9.7838Search in Google Scholar
8. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, et al. Body mass index references for Turkish children. Acta Paediatr 2006;95:194–8.10.1080/08035250500334738Search in Google Scholar
9. Hatipoglu N, Ozturk A, Mazicioglu MM, Kurtoglu S, Seyhan S, et al. Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents. Eur J Pediatr 2008;167:383–9.10.1007/s00431-007-0502-3Search in Google Scholar
10. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis,evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555–76.10.1542/peds.114.2.S2.555Search in Google Scholar
11. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, et al. International Diabetes Federation Task Force on epidemiology and prevention of diabetes. The metabolicsyndromein children and adolescents. Lancet 2007;369:2059–61.10.1016/S0140-6736(07)60958-1Search in Google Scholar
12. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivitycheck index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:500–3.10.1542/peds.2004-1921Search in Google Scholar PubMed
13. Tanner JM. Growth at adolescence, 2nd ed. Oxford, UK: Blackwell Scientific Publications, 1962.Search in Google Scholar
14. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, et al. Mannheim carotid intima-media thickness consensus (2004–2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007;23:75–80.10.1159/000097034Search in Google Scholar PubMed
15. Alemzadeh R, Rising R, Lifshitz F. Obesity in children. In: Lifshitz F, editor. Pediatricendocrinology. Volume 1. 5th ed. New York: Informa Healthcare, 2007:1–56.Search in Google Scholar
16. Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, et al. MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr. 2007;96:542–7.10.1111/j.1651-2227.2007.00186.xSearch in Google Scholar PubMed
17. Kannel WB. Blood pressure as cardiovascular risk factor: prevention and treatment. J Am Med Assoc 1996;275:1571–6.10.1001/jama.1996.03530440051036Search in Google Scholar
18. Di Bonito P, Capaldo B, Forziato C, Sanguigno E, Di Fraia T, et al. Central adiposity and left ventricular mass in obese children. Nutr Metab Cardiovasc Dis 2008;18:613–7.10.1016/j.numecd.2007.09.002Search in Google Scholar PubMed
19. Baysal T, Alp H, Koç N, Atabek ME, Eklioğlu BS, et al. Serum ischemia-modified albumin level and its association with cardiovascular risk factors in obese children and adolescents. J Pediatr Endocrinol Metab 2012;25:935–44.10.1515/jpem-2012-0191Search in Google Scholar PubMed
20. Nambi V, Chambless L, He M, Folsom AR, Mosley T, et al. Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur Heart J 2012;33:183–90.10.1093/eurheartj/ehr192Search in Google Scholar PubMed PubMed Central
21. Yücel O, Cevik H, Kinik ST, Tokel K, Aka S, et al. Abdominal aorta intima media thickness in obese children. J Pediatr Endocrinol Metab 2013;26:735–41.10.1515/jpem-2012-0297Search in Google Scholar PubMed
22. Alp H, Eklioğlu BS, Atabek ME, Karaarslan S, Baysal T, et al. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents. J Pediatr Endocrinol Metab 2014;27:827–35.10.1515/jpem-2013-0306Search in Google Scholar PubMed
23. Atabek ME, Eklioglu BS, Akyürek N, Alp H. Association between vitamin D level and cardiovascular risk in obese children and adolescents. J Pediatr Endocrinol Metab 2014;27:661–6.10.1515/jpem-2013-0379Search in Google Scholar PubMed
24. Sert A, Pirgon O, Aypar E, Yilmaz H, Odabas D. Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. J Pediatr Endocrinol Metab 2012;25:927–34.10.1515/jpem-2012-0187Search in Google Scholar PubMed
25. Alisi A, Manco M, Vania A, Nobili V. Pediatric nonalcoholic fatty liver disease in 2009. J Pediatr 2009;155:469–74.10.1016/j.jpeds.2009.06.014Search in Google Scholar PubMed
26. Kannisto K, Pietiläinen KH, Ehrenborg E, Rissanen A, Kaprio J, et al. Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. J Clin Endocrinol Metab 2004;89:4414–21.10.1210/jc.2004-0153Search in Google Scholar PubMed
27. Lea-Currie YR, Wen P, McIntosh MK. Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 1998;248:497–504.10.1006/bbrc.1998.8996Search in Google Scholar PubMed
28. Kawano H, Yasue H, Kitagawa A, Hirai N, Yoshida T, et al. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab 2003;88:3190–5.10.1210/jc.2002-021603Search in Google Scholar PubMed
29. Corvalán C, Uauy R, Mericq V. Obesity is positively associated with dehydroepiandrosterone sulfate concentrations at 7 y in Chilean children of normal birth weight. Am J Clin Nutr 2013;97:318–25.10.3945/ajcn.112.037325Search in Google Scholar PubMed PubMed Central
30. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper Biyokimya, Nobel Tıp Kitapevleri, Istanbul, 928 s.Search in Google Scholar
31. Koga M, Saito H, Mukai M, Saibara T, Kasayama S. Serum dehydroepiandrosterone sulphate levels in patients with non-alcoholic fatty liver disease. Int Med 2011;50:1657–61.10.2169/internalmedicine.50.4682Search in Google Scholar PubMed
32. Sumida Y, Yonei Y, Kanemasa K, et al. Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients. Hepatol Res 2010;40:901–10.10.1111/j.1872-034X.2010.00704.xSearch in Google Scholar PubMed
©2015 by De Gruyter
